Indian Drugmaker Glenmark Conducts Clinical Trials On Favipiravir, Potential COVID-19 Drug

Like
Like Love Haha Wow Sad Angry

Glenmark’s Clinical Trials On Favipiravir Potential Treatment for COVID-19 In India, clinical trials on Favipiravir Antiviral tablets for Covid-19 patients begins after the regulator (DCGI) gave approval for an Indian drugmaker to proceed. An integrated global and research-led pharmaceutical company, Glenmark Pharmaceuticals Ltd. announced that it has got approval to conduct trials with the drug […]

The post Indian Drugmaker Glenmark Conducts Clinical Trials On Favipiravir, Potential COVID-19 Drug appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/04/glenmarks-clinical-trials-on-favipiravir-potential-treatment-for-covid-19/

Like
Like Love Haha Wow Sad Angry